Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine

Clinical trial NCT00775463 · COMPLETED

Trial details

NCT number: NCT00775463
Sponsor: United Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis Scleroderma

Start date: 2009-05-01
Primary completion: 2011-03-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.